Skip to content

The evaluation of microbiome in liver abscess patients

The evaluation of microbiome in liver abscess patients requiring drainage or fine needle aspiration

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003857
Enrollment
100
Registered
2019-04-26
Start date
2019-05-31
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Catholic Kwandong University International St.Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Adult men and women over 20 years of age 2) A person who has signed a written agreement with a description of the purpose and method of clinical research 3) Patients requiring liver abscess drainage or fine-needle aspiration 4) Those who have participated in other clinical studies within 60 days before enrollment in this clinical study 5) A person who is judged to be inadequate in participating in clinical research <control group> 1) Adult men and women over 20 years of age 2) A person who has signed a written agreement with a description of the purpose and method of clinical research 3) A person whose alcohol intake is 30g or less for men or 20g or less for women. 4) Normal people without history of hypertension, diabetes and chronic hepatitis. 5) Without liver abscess and bacterial inflammatory disease (eg, pneumonia, pyelonephritis, abscess,

Exclusion criteria

Exclusion criteria: 1) Patients who received antibiotics for the treatment of symptoms associated with liver abscess before participating in the clinical study 2) women who are pregnant or lactating, whose pregnancies have been confirmed by means of pregnancy tests of serum or urine specimens, or who are planning a pregnancy during the test period or who are pregnant but do not use approved methods of contraception 3) Persons with bacterial inflammatory disease other than liver abscess (eg, pneumonia, pyelonephritis, abscess, sepsis, etc.) 4) Those who have participated in other clinical studies within 60 days before enrollment in this clinical study 5) Others Judged by the tester as inappropriate for participation in clinical research

Design outcomes

Primary

MeasureTime frame
Differences in distribution of intestinal microorganisms

Secondary

MeasureTime frame
Liver enzyme levels and inflammatory response in blood

Countries

Korea, Republic of

Contacts

Public ContactSangheun Lee

Catholic Kwandong University International St.Mary's Hospital

medsinger@naver.com+82-32-290-3878

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026